Mustang Bio is a clinical-stage biotechnology company that develops engineered cell therapies for treating cancers and autoimmune diseases. Their primary focus is on chimeric antigen receptor T cell programs currently undergoing various phases of human testing. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?
